Análise do strain por ressonância magnética em cardiomiopatia siderótica antes e após terapia de quelação de ferro

Capeline, Lorena Squassante; Rodrigues, Alfredo Augusto Eyer; Lopes, Cibele Gontijo; Zagonel, Davi Alberto; Gabardo, Maria Leticia; Barbosa, José Eduardo Martins; Correia, Edileide de Barros; Cury, Roberto Calderaro; Uellendahl, Marly Maria.
Arq. bras. cardiol ; 111(3 supl.1): 195-195, set., 2018.
Artículo en Portugués | SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1046094

Documentos relacionados

  1. The Role of Deferiprone in Iron Chelation.
  2. The Role of Deferiprone in Iron Chelation.
  3. The Role of Deferiprone in Iron Chelation. Reply.
  4. Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study.
  5. Cardiac iron overload evaluation in thalassaemic patients using T2* magnetic resonance imaging following chelation therapy: a multicentre cross-sectional study
  6. Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients.
  7. Hyaluronic acid-British anti-Lewisite as a safer chelation therapy for the treatment of arthroplasty-related metallosis.
  8. Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
  9. Multipurpose Iron-Chelating Ligands Inspired by Bioavailable Molecules.
  10. Kinetic aspects of iron(III)-chelation therapy with deferasirox (DFX) revealed by the solvolytic dissociation rate of the Fe(III)-DFX complex estimated with capillary electrophoretic reactor.